Takeda Pharmaceutical Co Ltd (TAK)
13.23
-0.08
(-0.60%)
USD |
NYSE |
May 17, 16:00
13.23
0.00 (0.00%)
After-Hours: 19:10
Takeda Pharmaceutical Free Cash Flow: 1.633B for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.633B |
| December 31, 2023 | -814.80M |
| September 30, 2023 | 1.008B |
| June 30, 2023 | 1.364B |
| March 31, 2023 | 2.544B |
| December 31, 2022 | 6.455B |
| September 30, 2022 | 6.696B |
| June 30, 2022 | 7.100B |
| March 31, 2022 | 8.347B |
| December 31, 2021 | 8.053B |
| September 30, 2021 | 7.229B |
| June 30, 2021 | 7.464B |
| March 31, 2021 | 7.306B |
| December 31, 2020 | 5.777B |
| September 30, 2020 | 4.623B |
| June 30, 2020 | 4.431B |
| March 31, 2020 | 4.159B |
| December 31, 2019 | 3.706B |
| September 30, 2019 | 3.688B |
| June 30, 2019 | 2.413B |
| March 31, 2019 | 1.753B |
| December 31, 2018 | 2.010B |
| September 30, 2018 | 2.030B |
| June 30, 2018 | 1.878B |
| March 31, 2018 | 2.253B |
| Date | Value |
|---|---|
| December 31, 2017 | 2.118B |
| September 30, 2017 | 1.408B |
| June 30, 2017 | 1.467B |
| March 31, 2017 | 1.381B |
| December 31, 2016 | -816.88M |
| September 30, 2016 | -221.51M |
| June 30, 2016 | -183.21M |
| March 31, 2016 | -494.72M |
| December 31, 2015 | 1.022B |
| September 30, 2015 | 884.98M |
| June 30, 2015 | 973.73M |
| March 31, 2015 | 674.86M |
| December 31, 2014 | 1.386B |
| September 30, 2014 | 1.357B |
| June 30, 2014 | 1.482B |
| March 31, 2014 | 700.90M |
| December 31, 2013 | 1.055B |
| September 30, 2013 | 1.200B |
| June 30, 2013 | 1.402B |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 |
Free Cash Flow Range, Past 5 Years
-814.80M
Minimum
Dec 2023
8.347B
Maximum
Mar 2022
4.659B
Average
4.527B
Median
Free Cash Flow Benchmarks
| Astellas Pharma Inc | 952.05M |
| Nxera Pharma Co Ltd | -49.09M |
| PeptiDream Inc | 6.450M |
| Healios KK | -19.34M |
| AnGes Inc | -- |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.999B |
| Cash from Investing (Quarterly) | -489.35M |
| Cash from Financing (Quarterly) | -450.06M |
| Free Cash Flow Per Share (Quarterly) | 0.4637 |
| Free Cash Flow to Equity (Quarterly) | 2.559B |
| Free Cash Flow to Firm (Quarterly) | 1.506B |
| Free Cash Flow Yield | 3.90% |